DrugPatentWatch Database Preview

EFFIENT Drug Profile

« Back to Dashboard

Which patents cover Effient, and what generic alternatives are available?

Effient is a drug marketed by Eli Lilly And Co and is included in one NDA.

The generic ingredient in EFFIENT is prasugrel hydrochloride. There are nineteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the prasugrel hydrochloride profile page.

Summary for EFFIENT

US Patents:	0
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	98
Clinical Trials:	46
Patent Applications:	98
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for EFFIENT
Drug Sales Revenues:	Drug sales revenues for EFFIENT
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for EFFIENT
DailyMed Link:	EFFIENT at DailyMed

See drug prices for EFFIENT

See drug sales revenues for EFFIENT

Recent Clinical Trials for EFFIENT

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Janssen, LP	Phase 4
Boston Scientific Corporation	Phase 2
HonorHealth Research Institute	Phase 2

See all EFFIENT clinical trials

Recent Litigation for EFFIENT

Identify potential future generic entrants

District Court Litigation

Case Name	Date
ELI LILLY AND COMPANY v. ACCORD HEALTHCARE INC., USA	2014-03-12
ELI LILLY AND COMPANY v. PAR PHARMACEUTICAL COMPANIES, INC.	2014-01-24

See all EFFIENT litigation

PTAB Litigation

Petitioner	Date
Lupin, Ltd.	2015-10-05
Panacea Biotec Ltd.	2015-06-26
Accord Healthcare Inc., USA	2015-03-13

See all EFFIENT litigation

Pharmacology for EFFIENT

Drug Class	P2Y12 Platelet Inhibitor
Mechanism of Action	P2Y12 Receptor Antagonists
Physiological Effect	Decreased Platelet Aggregation

Synonyms for EFFIENT

[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxidanylidene-ethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] ethanoate

[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxo-ethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate

[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate

[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[4,5-c]pyridin-2-yl] acetate

150322-43-3

2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone

2-Acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c] pyridine

2-acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine

2-Acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)4,5,6,7-tetrahydrothieno[3,2-c]pyridine

2-acetyloxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine

2-acetyloxy-5-(alpha-cycloproylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-C]pyridine

322P433

5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate

5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate

5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-2-yl acetate

A809033

AB0005241

AB01274761_02

AB01274761-01

AB1008453

ABP000379

AC-1640

AC1OCFGI

acetic acid [5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] ester

Acetic acid 5-[2-cyclopropyl-1-(2-fluoro-phenyl)-2-oxo-ethyl]-4,5,6,7-tetrahydro-thieno[3,2-c]pyridin-2-yl ester

ACN-040194

ACT06208

AK327587

AKOS015841187

AM20090728

AN-605

API0003912

BC683564

BCP01882

C-58278

CHEBI:87723

CHEMBL1201772

CP0097

CS 747

CS-0657

CS-747

DB06209

DTGLZDAWLRGWQN-UHFFFAOYSA-N

Efient

EN002851

ETH051

Ethanone, 2-(2-(acetyloxy)-6,7-dihydrothieno(3,2-c)pyridin-5(4H)-yl)-1-cyclopropyl-2-(2-fluorophenyl)-

Ethanone, 2-[2-(acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)-

FC1274

FD7194

FT-0650150

GTPL7562

HMS3604B09

HMS3654D09

HSDB 7995

HY-15284

I06-2111

KB-40650

KS-00000XJY

KS-5301

LY-640315

LY640315

MCULE-1302242257

MLS003882595

MLS006012001

MolPort-006-395-740

NCGC00188690-01

NCGC00188690-02

P2040

PB23765

Prasita

Prasugrel

Prasugrel (Effient)

Prasugrel [INN:BAN]

Prasugrel, >=98% (HPLC)

prasugrel, 2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone

Prasugrel, 98%

Prasugrel/Effient

PubChem19523

Q-101872

Q-1607

RL01920

s1258

SB20805

SC-20714

SCHEMBL14112007

SCHEMBL245032

SMR002533665

STL232602

SW219175-1

W0064

ZLA0001

zlchem 1

Paragraph IV (Patent) Challenges for EFFIENT

Tradename	Dosage	Ingredient	NDA	Submissiondate
EFFIENT	TABLET;ORAL	prasugrel hydrochloride	022307	2013-07-10

US Patents and Regulatory Information for EFFIENT

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Eli Lilly And Co	EFFIENT	prasugrel hydrochloride	TABLET;ORAL	022307-001	Jul 10, 2009	AB	RX	Yes	No
Eli Lilly And Co	EFFIENT	prasugrel hydrochloride	TABLET;ORAL	022307-002	Jul 10, 2009	AB	RX	Yes	Yes
Eli Lilly And Co	EFFIENT	prasugrel hydrochloride	TABLET;ORAL	022307-001	Jul 10, 2009	AB	RX	Yes	No
Eli Lilly And Co	EFFIENT	prasugrel hydrochloride	TABLET;ORAL	022307-002	Jul 10, 2009	AB	RX	Yes	Yes

Expired US Patents for EFFIENT

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Eli Lilly And Co	EFFIENT	prasugrel hydrochloride	TABLET;ORAL	022307-001	Jul 10, 2009
Eli Lilly And Co	EFFIENT	prasugrel hydrochloride	TABLET;ORAL	022307-002	Jul 10, 2009